Lista de obras - Antonio Mazzocca - Dominio Público Uruguay

A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions

artículo científico publicado en 2005

A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm.

artículo científico publicado en 2016

ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer

artículo científico publicado en 2017

Autotaxin is a novel molecular identifier of type I endometrial cancer

artículo científico publicado en 2018

Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.

artículo científico publicado en 2004

Cell fusion promotes chemoresistance in metastatic colon carcinoma

artículo científico publicado en 2012

Circulating Levels of PAI-1 and SERPINE1 4G/4G Polymorphism Are Predictive of Poor Prognosis in HCC Patients Undergoing TACE.

artículo científico publicado en 2015

Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer

Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.

artículo científico publicado en 2013

Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.

artículo científico publicado en 2013

Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.

artículo científico publicado en 2010

Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide

artículo científico publicado en 2012

Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment

artículo científico publicado en 2017

Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer

artículo científico publicado en 2010

Frictional purpuric eruption associated with angiotensin II receptor blockers

artículo científico publicado en 2013

Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin

artículo científico publicado en 1999

Implications of the lysophosphatidic acid signaling axis in liver cancer.

artículo científico publicado en 2017

Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection

artículo científico publicado en 2012

Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L

artículo científico publicado en 2020

Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link?

artículo científico publicado en 2010

Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study.

artículo científico publicado en 2010

Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma

artículo científico publicado en 2015

Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D.

artículo científico publicado en 2017

Moving the systemic evolutionary approach to cancer forward: Therapeutic implications

artículo científico publicado en 2018

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

artículo científico publicado en 2017

Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function

artículo científico publicado en 2019

Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.

artículo científico publicado en 2006

PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma

artículo científico publicado en 2012

PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.

artículo científico publicado en 2011

Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro

artículo científico publicado en 2014

Reply: To PMID 21674557

artículo científico publicado en 2013

SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.

artículo científico publicado en 2012

Sorafenib: 10 years after the first pivotal trial.

artículo científico

Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.

artículo científico publicado en 2015

Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells

artículo científico publicado en 2004

Tetraspanin-enriched microdomains and hepatocellular carcinoma progression

artículo científico publicado en 2014

Tetraspanins CD9 and CD81 are molecular partners of trimeric FcɛRI on human antigen-presenting cells

artículo científico publicado en 2011

The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System

scientific article published on 02 October 2019

The TGF-β signaling pathway as a pharmacological target in a hepatocellular carcinoma

artículo científico publicado en 2012

The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells.

artículo científico publicado en 2001

The metastatic process: methodological advances and pharmacological challenges.

scientific article published on January 2009

The perplexity of targeting genetic alterations in hepatocellular carcinoma

artículo científico publicado en 2020

The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer

artículo científico publicado en 2014

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.

artículo científico publicado en 2009

Topology of the mitochondrial cAMP-dependent protein kinase and its substrates

artículo científico publicado en 1996

Lista de obras de Antonio Mazzocca

A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions

A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigm.

ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer

Autotaxin is a novel molecular identifier of type I endometrial cancer

Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells.

Cell fusion promotes chemoresistance in metastatic colon carcinoma

Circulating Levels of PAI-1 and SERPINE1 4G/4G Polymorphism Are Predictive of Poor Prognosis in HCC Patients Undergoing TACE.

Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer

Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.

Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II.

Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.

Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide

Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment

Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer

Frictional purpuric eruption associated with angiotensin II receptor blockers

Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin

Implications of the lysophosphatidic acid signaling axis in liver cancer.

Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection

Inhibition of Hepatocellular Carcinoma Growth by Ethyl Acetate Extracts of Apulian Brassica oleracea L. and Crithmum maritimum L

Involvement of ADAMs in tumorigenesis and progression of hepatocellular carcinoma: Is it merely fortuitous or a real pathogenic link?

Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study.

Lysophosphatidic acid receptor LPAR6 supports the tumorigenicity of hepatocellular carcinoma

Metabolic syndrome and Chronic Obstructive Pulmonary Disease (COPD): The interplay among smoking, insulin resistance and vitamin D.

Moving the systemic evolutionary approach to cancer forward: Therapeutic implications

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function

Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.

PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma

PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.

Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro

Reply: To PMID 21674557

SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study.

Sorafenib: 10 years after the first pivotal trial.

Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.

Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells

Tetraspanin-enriched microdomains and hepatocellular carcinoma progression

Tetraspanins CD9 and CD81 are molecular partners of trimeric FcɛRI on human antigen-presenting cells

The Systemic-Evolutionary Theory of the Origin of Cancer (SETOC): A New Interpretative Model of Cancer as a Complex Biological System

The TGF-β signaling pathway as a pharmacological target in a hepatocellular carcinoma

The integrin, alpha6beta1, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocarcinoma cells.

The metastatic process: methodological advances and pharmacological challenges.

The perplexity of targeting genetic alterations in hepatocellular carcinoma

The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer

Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC.

Topology of the mitochondrial cAMP-dependent protein kinase and its substrates